Literature DB >> 29345412

WNT5A promotes migration and invasion of human osteosarcoma cells via SRC/ERK/MMP-14 pathway.

Xingwen Wang1,2, Xin Zhao1,2, Zhigang Yi1,2, Bing Ma1,2, Hong Wang1,2, Yanchuan Pu1,2, Jing Wang2, Shuanke Wang1,2.   

Abstract

WNT5A, a representative ligand of activating several non-canonical WNT signal pathways, plays significant roles in oncogenesis and tumor inhibition. It has been shown that the non-receptor tyrosine kinase SRC is required for WNT5A-induced invasion of osteosarcoma cells. However, the precise molecular mechanism underlying WNT5A/SRC-mediated osteosarcoma cells invasion remains poorly defined. The study was designed to explore the role of ERK1/2 in WNT5A/SRC-induced osteosarcoma cells invasion and the downstream target of the SRC/ERK1/2 signalings. We found that WNT5A (100 ng/mL) remarkably stimulated migration and invasion of human osteosarcoma MG-63 cells, whereas inhibiting either SRC kinase activity by siRNA-mediated SRC silence or ERK1/2 phosphorylation by PD98059 treatment suppressed these effects, which suggested that the activation of SRC and ERK1/2 is essential for WNT5A-induced MG-63 cells migration and invasion. Furthermore, ERK1/2 phosphorylation induced by WNT5A was dramatically blocked by SRC siRNA. Additionally, our study further demonstrated that MMP-14 was upregulated after exposure to WNT5A in MG-63 cells, and the increased expression was blocked by SRC siRNA or PD98059. Collectively, these results indicate that WNT5A activates SRC/ERK1/2 signal pathway, leading to the upregulation of MMP-14 expression and MG-63 cells migration and invasion.
© 2018 International Federation for Cell Biology.

Entities:  

Keywords:  MAP kinase signaling system; SRC-family kinases; WNT5A; metastasis; osteosarcoma

Mesh:

Substances:

Year:  2018        PMID: 29345412     DOI: 10.1002/cbin.10936

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  6 in total

1.  Extracellular vesicles from bone mesenchymal stem cells transport microRNA-206 into osteosarcoma cells and target NRSN2 to block the ERK1/2-Bcl-xL signaling pathway.

Authors:  Alimu Keremu; Pazila Aila; Aikebaier Tusun; Maimaitiaili Abulikemu; Xiaoguang Zou
Journal:  Eur J Histochem       Date:  2022-06-22       Impact factor: 1.966

2.  PTPN3 suppresses lung cancer cell invasiveness by counteracting Src-mediated DAAM1 activation and actin polymerization.

Authors:  Meng-Yen Li; Wen-Hsin Peng; Chien-Hsun Wu; Ya-Min Chang; Yu-Ling Lin; Geen-Dong Chang; Han-Chung Wu; Guang-Chao Chen
Journal:  Oncogene       Date:  2019-08-12       Impact factor: 9.867

3.  DCLK1 Plays a Metastatic-Promoting Role in Human Breast Cancer Cells.

Authors:  Heshu Liu; Tao Wen; Ying Zhou; Xiaona Fan; Tan Du; Tianbo Gao; Lina Li; Jian Liu; Lei Yang; Jiannan Yao; Yang Ge; Guangyu An
Journal:  Biomed Res Int       Date:  2019-05-15       Impact factor: 3.411

4.  Wnt signaling and Loxl2 promote aggressive osteosarcoma.

Authors:  Kazuhiko Matsuoka; Latifa Bakiri; Lena I Wolff; Markus Linder; Amanda Mikels-Vigdal; Ana Patiño-García; Fernando Lecanda; Christine Hartmann; Maria Sibilia; Erwin F Wagner
Journal:  Cell Res       Date:  2020-07-20       Impact factor: 25.617

Review 5.  Chemoresistance-Related Stem Cell Signaling in Osteosarcoma and Its Plausible Contribution to Poor Therapeutic Response: A Discussion That Still Matters.

Authors:  Sara R Martins-Neves; Gabriela Sampaio-Ribeiro; Célia M F Gomes
Journal:  Int J Mol Sci       Date:  2022-09-27       Impact factor: 6.208

6.  Wnt5a enhances proliferation of chronic lymphocytic leukemia and ERK1/2 phosphorylation via a ROR1/DOCK2-dependent mechanism.

Authors:  Md Kamrul Hasan; Emanuela M Ghia; Laura Z Rassenti; George F Widhopf; Thomas J Kipps
Journal:  Leukemia       Date:  2020-10-23       Impact factor: 11.528

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.